News from the EMA - Volume 31, Issue

The articles included in this section are a selection from the European Medicines Agency (EMA)’s News and Press Releases archive. More information can be found on the Agency’s website: www.ema.europa.eu. Anuradha Alahari (editor)

Passing the torch - Volume 21, Issue

This issue is the first where I will be serving as Editor-in-Chief of Medical Writing (MEW). Elise Langdon-Neuner, Editor-in-Chief since 2004, will be stepping down. This is yet another step in the evolution of the journal.

For those of you unfamili…

The Crofter: Sustainable Communications - Volume 30, Issue

Greetings from the croft! In this special issue on medical journalism, we have two contributions that discuss topics that have enjoyed attention in the press: 1. the emerging environmental problem because of the growing drug market for pets, and 2.…

Good Writing Practice - Volume 26, Issue

Syntactic Structure - Inter-sentenceIncrementalism: SentencesInter-sentence incrementalism is an expansion of information, often secondary, into a sentence rather than a reduction of the information to a clause or phrase and incorporation (sentence…

Carbon footprint of EMWA activities: A first estimate - Volume 32, Issue

The Sustainability Special Interest Group (SUS-SIG) of EMWA was established in 2020 to support the United Nations 2030 agenda for sustainable development from the perspective of a not-for-profit professional organisation for medical writers and…

Are stem cells the future of healthcare? - Volume 21, Issue

Stem cell technology holds a key, although arguably not an exclusive position, in the future of healthcare. Alongside two other candidates worthy of this mantle – personalized cancer medicine and vaccine development – all three healthcare…

Medical Communications and Writing for Patients - Volume 32, Issue

Introducing a new EMWA Special Interest Group: Communicating with the Public Contributors: Sampoorna Rappaz (author), Lisa Chamberlain James (section editor) The Communicating with the Public Special Interest Group (CwP SIG) held its first Meet…

For the greater good…Can agency competitors cooperate to advance medical publication practices? - Volume 24, Issue

The business of medical writing is competitive, but can it be cooperative? Is it time for agencies, which provide professional and ethical publication support to authors, to cooperate for the greater good of the medical publication profession?…

If a misinformed voice speaks out in the wilderness and no one refutes it, does it make a sound? A call to advocacy - Volume 22, Issue

The pharmaceutical industry has been a soft target for many years. Attacks by journalists, politicians, and the lay public tend to be triggered by publications with which professional medical writers are associated. Fault is found, either in the…

An introduction to little-known aspects of nonclinical regulatory writing - Volume 26, Issue

Nonclinical evaluation is a key component of drug development. Traditionally, scientists have prepared much of the written regulatory documentation, with dedicated nonclinical writing being a niche profession. This is changing – the demand for…